Fang Le Shu (Follitrope)

Phase 3Small molecule

LLG Chem

Fang Le Shu (Follitrope) is one of 13 small molecule programs targeting Female Infertility. It is currently in Phase 3.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Female InfertilityActive, not recruiting

Female InfertilityPhase 3

Active, not recruiting

Competition

Competitive Landscape

12 competitors in Female Infertility

#DrugCompanyPhaseTrials

Clomid

Orgalutran

Acetadote

AArbor Pharmaceuticals, Inc.

Approved

—4

Gynorest

SSolvay Pharmaceuticals

Prometrium

Viagra

VViatris Specialty LLC

Approved

—7

Fang Le Shu (Follitrope)

LLG Chem

Phase 3

1 8

Estrasorb

Tractocile

Gonal-F

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q4 2026

ApprovedActive, not recruiting

Female Infertility

NCT06921395

Clinical

Trials by Indication[1]

Female Infertility1 trial

A Phase IV, Prospective, Randomized, Open-label, Active-controlled, Parallel-group, Multicenter Study to Evaluate Efficacy and Safety of Fang Le Shu (Recombinant FSH) Versus Guo Na Fen Used for Controlled Ovarian Stimulation in Infertile Women Undergoing In Vitro Fertilization-Embryo Transfer.

Active, not recruiting·LLG Chem·Approved·NCT06921395·248 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Fang Le Shu (Follitrope). U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Fang Le Shu (Follitrope) compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Fang Le Shu (Follitrope). EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — LG Chem company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 3[1]
Company: LLG Chem

Fang Le Shu (Follitrope)

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q4 2026

Trials by Indication[1]

Female Infertility1 trial

References

Drug Info

Quick Facts

Related News